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 Abstract 
 Dynamic DNA methylation is a prerequisite for many devel-
opmental processes and maintenance of cellular integrity. In 
mammals however, mechanisms of active DNA demethylation 
have for long been elusive. The discovery of the ten-eleven 
translocation (Tet) family of enzymes that oxidize 5-meth-
ylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 
5-formylcytosine (5fC) or 5-carboxylcytosine (5caC) pro-
vided new means by which DNA methylation could actively 
be reversed. This review focuses on the possible mechanisms 
of DNA demethylation via Tet proteins and their metabolites 
5hmC, 5fC and 5caC. Additionally, it discusses the roles of 
the three Tet protein family members Tet1, Tet2 and Tet3 as 
developmental regulators, probably in part independent of 
their enzymatic activity. By contrast, recent evidence sug-
gests a function of 5hmC as an epigenetic mark on its own, 
going beyond the expectation of only acting as an intermedi-
ate in an active DNA demethylation pathway. 
 Keywords:  DNA demethylation;  epigenetics;  5-hydroxy-
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 Introduction 
 Development of a healthy organism requires the orchestra-
tion of complex mechanisms for correct interpretation of the 
underlying genomic information. This process starts with the 
formation of a totipotent one-cell embryo that needs to con-
fi gure its gene expression program to ensure proper subse-
quent cell divisions and differentiation of tissues and organs 
forming an adult organism. 
 Cellular differentiation involves transcription factor medi-
ated gene regulation and fl exible modifi cation of chromatin 
structure (DNA tightly wrapped around basic histones form-
ing nucleosomes). Combinations of various post-translational 
modifi cations of histones (e.g., methylation or acetylation), 
as well as addition of small chemical groups (e.g., methyl 
groups) to DNA bases constitute the heritable epigenetic pro-
fi le of a specifi c cell type. As a consequence, a cell-intrinsic 
gene expression program is established and maintained. 
 DNA methylation, here referred to as the methylation of 
the cytosine base at the fi fth position of the pyrimidine ring 
(5-methylcytosine, 5mC) occurs almost exclusively in a CpG 
context (where a guanine follows a cytosine in the DNA 
sequence)  (1) . DNA methylation has been associated with 
a variety of different regulatory processes in mammals. It is 
a hallmark of differentiated cells, where it mediates stable 
gene silencing that is essential for the maintenance of cel-
lular integrity  (2, 3) . DNA methylation is also involved in 
the control of gene dosage in the context of X chromosome 
inactivation (the process whereby one of the two X chromo-
somes in females is transcriptionally silenced) and genomic 
imprinting, where it controls the parent-of-origin expression 
of alleles via the sex-specifi c methylation of imprint control 
regions  (4 – 6) . It is furthermore needed to repress transpos-
able elements, whose activation might otherwise damage the 
DNA  (7) . Methylation of cytosine on DNA is catalyzed by the 
DNA methyltransferases (Dnmts) Dnmt1, Dnmt 3a and 3b, 
which are required for maintenance and  de novo methylation, 
respectively  (8 – 10) . 
 Although DNA methylation is essential for survival, some 
natural processes require its reversal  (11) . Upon fertilization of 
the oocyte, the paternal (sperm) genome rapidly loses global 
methylation  (12) . Later in embryogenesis, primordial germ 
cells (PGCs), the developing  ‘ founder ’ germ cells that are 
formed in implanted embryos, erase their parentally inherited 
genomic imprints. After erasure, PGCs acquire new imprints 
according to their sex. These are then ultimately transmitted 
to the subsequent generation by means of male and female 
germ cells in the adult organism  (13) . Interestingly, loss of 
DNA methylation often coincides with the requirement of 
reaching a pluripotent cell fate, such as in PGCs and in cells 
of the early embryo. Although in mammals scenarios involv-
ing rapid decrease in DNA methylation have been known 
for years, a longstanding search for pathways involved has 
only recently begun to reveal some of the details  (14) . By 
contrast, active DNA demethylation pathways in plants have 
been extensively studied. Plants harbor enzymes of the base 
excision repair (BER) machinery that recognize 5mC as a 
substrate  (15) . The modifi ed base is subsequently removed 
by the activity of a glycosylase that cuts the sugar backbone 
of the DNA and replaces the gap by the unmodifi ed base ana-
log. However, animals lack homologous BER enzymes hav-
ing high affi nity towards 5mC  (14, 15) . One widely accepted 
scenario for removing DNA methylation is the inhibition of 
Dnmts, whose function in the maintenance of methylation 
occurs through recognition of hemimethylated DNA and 
propagation of 5mC upon replication  (16 – 18) . However, this 
passive loss of methylation is slow and requires cell division. 
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Therefore, it cannot explain the rapid demethylation, for 
example, of the paternal genome in the fertilized oocyte in 
the absence of cell division. Until recently, it had remained 
unclear what mechanisms might trigger active DNA demeth-
ylation, as none of the proposed models had so far provided 
suffi cient answers  (14, 15, 17, 18) . 
 A new enzyme class converting methylated 
cytosines 
 The discovery of a conserved enzyme family generating the 
 ‘ sixth base ’ 5-hydroxymethylcytosine (5hmC) focused broad 
attention. The ten-eleven translocation (Tet) protein family 
of 2-oxoglutarate (2OG)- and Fe(II)-dependent enzymes can 
convert 5mC to 5hmC by hydroxylation of the methyl group 
 (19, 20) . At the same time, Kriaucionis and Heintz reported 
abundant 5hmC, originally identifi ed as nucleic acid compo-
nent in viruses, in mammalian brain cells  (21, 22) . The detec-
tion of Tet proteins and 5hmC in mammals provided a new 
direction in the search for active DNA demethylation path-
ways, as 5hmC could serve as an intermediate to generate 
unmodifi ed cytosine. 
 The Tet enzyme family consists of three members, Tet1, 
2 and 3, which have a distinct expression pattern throughout 
development but tend to be expressed highest in undifferenti-
ated, pluripotent cell types (Figure  1 ). Tet3 levels are highest 
in oocytes persisting after fertilization and decreasing with the 
fi rst two embryonic cleavages, when Tet1 and 2 become acti-
vated  (23) . Whereas Tet1 and, to a lesser extent, Tet2 become 
abundant in preimplantation embryos, their protein levels 
decrease in cells undergoing differentiation in implanted 
developing embryos with the exception of some cell types 
of the brain  (23) . In adults, Tet2 is highly expressed in cells 
of the hematopoietic system and is frequently downregulated 
or subjected to loss-of-function mutations in related cancer 
cells, which is reviewed in  (24) . Concomitant with the pres-
ence of Tet family proteins, 5hmC is relatively abundant in 
oocytes, in the early embryo and in some brain cells  (25 – 27) . 
By contrast, most mammalian adult tissues show very low 
levels of 5hmC  (25, 27) . Hence, the presence of Tet proteins 
and 5hmC globally anticorrelates with cellular differentiation 
and high DNA methylation levels. 
 Tet protein function in mouse embryonic stem 
cells 
 Pluripotent embryonic stem cells (ESCs) are derived from the 
inner cell mass (ICM), a cluster of pluripotent cells that will 
form the embryo proper after implantation of the blastocyst (a 
late preimplantation embryo bearing an outer layer of epithe-
lial trophoblast cells (trophectoderm, TE) surrounding a fl uid-
fi lled cavity and the ICM). ESCs express high levels of Tet1 
and intermediate levels of Tet2 and, consistently, abundant 
5hmC  (20, 28 – 32) . Hence, these pluripotent cells have served 
as an excellent model system to study biological functions of 
Tet proteins and DNA demethylation mechanisms via 5hmC. 
 One of the fi rst descriptions of Tet1 function focused on 
its role in the maintenance of pluripotency in ESCs  (20) . 
Lentivirus-mediated depletion of Tet1 protein by knockdown 
(kd) approaches using small hairpin RNAs (shRNAs) impaired 
the capacity of ESC self-renewal and led to upregulation of 

















 Figure 1  Tet protein dynamics in early embryonic development. 
 Tet3 is abundant in the oocyte and remains present at high levels after fertilization in the zygote. In two-cell embryos Tet3 levels rapidly 
decrease, when  Tet1 and  Tet2 start to become activated. Tet1 and Tet2 are highly expressed in the inner cell mass (ICM) but not in the tro-
phectoderm (TE) of the blastocyst (the late preimplantation embryo). Tet protein levels decrease upon differentiation of embryonic stem cells 
[(ESCs) derived from the ICM) and, therefore, probably also in the epiblast (cells of the implanted embryo, which will give rise to the embryo 
proper]. At embryonic day (E) 6.5 primordial germ cells (PGCs), which will differentiate into mature germ cells, are specifi ed from the pos-
terior proximal epiblast. Tet1 and Tet2 levels increase upon PGC development. Dashed lines represent putative and straight lines represent 
experimentally validated expression. 
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crosstalk between the pluripotency factor  Nanog and Tet1 by 
its binding to the  Nanog promoter, which probably causes the 
altered ESC fate upon Tet1 removal. Nevertheless, the func-
tion of Tet1 in maintenance of pluripotency in ESCs is still 
debated  (20, 29, 30, 33, 34) . Several independent studies of 
genome-wide Tet1 occupancy in ESCs using different anti-
bodies against Tet1 have shown a high degree of overlap of 
Tet1 binding sites, to as much as 90 % between comparable 
analyses  (30 – 32, 35) . These studies revealed that Tet1 prefers 
binding within intragenic regions, predominantly at regions 
that contain clusters of CpG dinucleotides forming CpG 
islands (CGIs) present in two-thirds of all vertebrate gene 
promoters. These regions are generally hypomethylated in 
ESCs and enriched for histone modifi cation Histone 3 lysine 
4 trimethylation (H3K4me3), an epigenetic mark associated 
with active transcription  (2, 36, 37) . At some CGIs additional 
Histone 3 lysine 27 trimethylation (H3K27me3), a mark indi-
cating gene repression, is present generating a bivalent epi-
genetic state  (2) . Tet1 is also enriched around transcriptional 
start sites (TSSs) of CpG rich promoters, suggesting a role in 
transcriptional regulation of these genes  (30 – 32, 35) . Indeed, 
depletion of Tet1 by kd approach alters the gene expression 
level of some of its targets. Although the predicted function 
of Tet1 was to counteract repressive DNA methylation, not 
all Tet1 target genes become silenced upon removal of the 
enzyme. In fact, only 10 % of Tet1 marked genes alter their 
expression level and more than half of the latter are upre-
gulated upon Tet1 kd, suggesting that Tet1 can play a dual 
role in transcriptional regulation  (30 – 32, 35) . Thus, deple-
tion of the Tet1 enzyme leads to a global reduction of 5hmC 
refl ecting its role in enzymatic conversion of 5mC in ESCs. 
Simultaneously, only a minor global, but a detectable local 
increase in DNA methylation at single genes becomes appar-
ent, which might contribute to transcriptional regulation at 
these sites. Tet1-activated genes are enriched for those having 
a housekeeping function, whereas the Tet1-repressed fraction 
mainly harbors developmental regulators. Co-occurrence of 
Tet1 with either H3K4me3 alone or with bivalent H3K4me3 
and H3K27me3 modifi cations seems to have a predictive 
potential of active transcription or gene silencing, respectively 
 (30, 31) . Polycomb repressive complex 2 (PRC2) proteins that 
establish repressive H3K27me3 marks overlap with around 
95 % of all Tet1-repressed genes  (30, 31) . Of these a major 
fraction loses PRC2 occupancy upon Tet1 depletion in ESCs, 
although no direct interaction of Tet1 and PRC2 complex 
members was identifi ed. This suggests that PRC2 recruitment 
to most of its target genes depends on Tet1 binding, although 
the mechanism of this interplay remains elusive. A subfrac-
tion of the Tet1-repressed genes shows colocalization with the 
Sin3A co-repressor, which directly binds to Tet1 and presum-
ably mediates transcriptional silencing through interaction 
with chromatin remodeling complexes at these sites  (30) . 
 The function of Tet1 in regulating gene expression might 
be in part independent of its enzymatic activity. Interestingly, 
the lack of DNA methylation (and hydroxymethylation) in 
ESCs (induced by mutation of all three Dnmt enzymes [Dnmt 
triple knockout (TKO) ESCs]) does not affect their self-re-
newal and pluripotency  (38) . These cells even retain a gene 
expression pattern similar to that of wild type ESCs and only 
show cellular defects upon induction of differentiation  (39) . 
TKO ESCs additionally depleted for Tet1 by kd show a simi-
lar set of up- and downregulated genes as compared to wild 
type ESCs upon Tet1 kd. This result suggests a regulatory role 
for Tet1 in transcription beyond its catalytic activity, as 5hmC 
is absent in TKO ESCs  (30) . However, this requires confi rma-
tion, for example, through genetic approaches using catalyti-
cally inactive Tet proteins. 
 Establishment of techniques for genome-wide 
analysis of 5hmC 
 As 5hmC had been a largely uncharacterized modifi ed base, 
its functional analysis in the mammalian genome provided 
a technical challenge. The classical technique to distinguish 
methylated from unmethylated cytosines, bisulfi te conver-
sion of DNA, is not suitable for the distinction of 5mC and 
5hmC bases  (40) . As commonly used methods to investigate 
the role of 5hmC were unavailable, many groups developed 
specifi c techniques for mapping genome-wide distribution of 
the hydroxylated base. Several 5hmC specifi c antibodies were 
generated and were applied for hydroxymethyl-DNA immuno-
precipitation followed by high-throughput sequencing (hMe-
DIP-Seq) or to whole-genome tiling microarrays  (23, 28 – 30, 
32) . In addition, several chemical labeling and enzyme-based 
methods for detection of 5hmC in the genome were estab-
lished  (28, 41) . Two chemical labeling based approaches are 
supposed to be highly sensitive to detection of even single 
5hmC bases  (28) . One method entails enzymatic addition of 
one glucose molecule to the hydroxymethyl group in 5hmC 
(glucose ligation biotinylation, GLIB). The covalently linked 
glucose is subsequently oxidized and coupled to biotin, which 
is then isolated by its affi nity to streptavidin. Another conver-
sion based method takes advantage of chemical conversion 
of 5hmC to cytosine 5-methylenesulfonate (CMS), which 
is recognized by an anti-CMS antibody. The GLIB and the 
CMS method were coupled to massive parallel sequencing 
for genome-wide localization of 5hmC in ESCs, providing 
similar results but increased sensitivity as compared to the 
use of anti-5hmC antibodies. However, relative genome-wide 
comparison of 5mC and 5hmC levels had not been possible 
until very recently: the oxidative bisulfi te sequencing method 
for single base resolution allows to quantify levels of 5hmC 
relative to 5mC in the genome  (42) . 
 Functional roles of 5 hmC: demethylation 
intermediate or regulatory mark ? 
 Similar to Tet1, 5hmC is enriched at intragenic regions and 
enhancers in ESCs  (23, 28, 30, 43) . However, in contrast to 
the enzyme Tet1, 5hmC seems to be preferentially present at 
genes with intermediate CpG content and to be less abundant 
at CGIs, revealing some non-overlapping sites of Tet1 enzyme 
and its product in the genome  (30, 42, 43) . The Tet1 non-
bound sites positive for 5hmC could refl ect the contribution of 
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Tet2 to hydroxymethylation at so far unknown Tet2 target sites 
in ESCs, as it is also expressed in ESCs but has not yet been 
mapped in the genome. Alternatively, 5hmC might function 
as a regulatory mark on its own, for example, regulating tran-
scription, serving for repulsion of Dnmts or regulating acces-
sibility of epigenetic players such as chromatin remodelers. 
 Some CGIs show low 5hmC but abundant Tet1 binding 
arguing for rapid processing of 5hmC at these sites. One 
suggested pathway includes the action of AID/Apobec (acti-
vation-induced cytidine deaminase/apolipoprotein B mRNA-
editing, enzyme catalytic, polypeptide family) deaminases 
that convert 5hmC to 5-hydroxymethyluracil (5hmU)  (44) . 
The latter is subsequently processed by glycosylases that cut 
the DNA backbone, for example, Thymine DNA glycosylase 
(TDG) or single-strand monofunctional uracil DNA glycosy-
lase (SMUG1)  (44, 45) . An alternative model proposes that Tet 
proteins oxidize 5mC to 5hmC that is subsequently oxidized 
to 5-formylcytosine (5fC) and fi nally to 5-carboxylcytosine 
(5caC)  (46) . The oxidation product 5caC serves as a sub-
strate for the glycosylase TDG and is replaced by unmodifi ed 
cytosine  (47) . Alternatively, 5caC could be decarboxylated to 
generate unmodifi ed cytosine, although no enzyme for this 
step has been identifi ed so far  (46) . The process of full oxida-
tion of 5mC to 5caC might be dependent on the stability of Tet 
enzyme binding, which seems to be increased at CpG dense 
regions. It is also conceivable that unknown co-factors add to 
this process and that several pathways contribute additively to 
DNA demethylation, possibly in a chromatin structure or cell 
type-dependent manner. 
 The high abundance of 5hmC and the reduced presence 
of Tet1 at sites of intermediate CpG density suggest a tran-
sient low-affi nity binding of the enzyme and subsequent sta-
bilization of hydroxymethylation in this context  (42) . The 
stability of 5hmC suggests a function independent of being 
an active demethylation intermediate. However, presence 
of DNA hydroxymethylation within genes does not corre-
late with either an active or a repressed transcriptional state, 
suggesting that 5hmC is not a predictive mark for transcrip-
tion  per se  (30, 48) . Distribution of 5hmC along the length 
of genes revealed distinct density profi les that seem to be 
more predictive for gene activity: genes that are depleted 
from 5hmC around TSSs, but contain higher 5hmC levels at 
their 3  ends tend to be active. By contrast, genes harboring 
abundant 5hmC at TSSs and promoter sequences tend to be 
silent, although results from different studies are somewhat 
inconsistent  (29, 35, 48) . 
 Unlike Tet1, 5hmC is enriched at enhancer regions, 
which regulate the transcriptional activity of linked genes. 
Interestingly, these regions typically show relatively low 
methylation levels in ESCs  (42, 49, 50) . This might refl ect 
sequence-specifi c binding of transcription factors contribut-
ing to an open chromatin confi guration, as methylated cyto-
sines recruit methyl-CpG-binding domain proteins (Mbds) 
that support gene silencing  (50, 51) . Hence, conversion of 
5mC to 5hmC might inhibit the binding of repressive Mbds or 
of Dnmts, thereby generating a hypomethylated state acces-
sible for regulatory complexes for induction of transcriptional 
activity at downstream genes. 
 A recent study that aimed at investigating the role of sev-
eral chromatin remodelers in ESC pluripotency revealed a 
new player in the read-out of 5hmC. Unlike other Mbd fam-
ily members that recognize 5mC only, the methyl-binding 
domain protein 3 (Mbd3) binds to hydroxy methylated DNA, 
probably due to the unique structure of its Mbd binding 
pocket  (52) . Mbd3 is a subunit of the silencing Nucleosome 
Remodeling and Deacetylase (NuRD) chromatin remodeling 
complex and colocalizes with PRC2 and Tet1 at sites pos-
sessing elevated 5hmC levels in ESCs. Moreover, depletion 
of Mbd3 by a kd approach in ESCs leads to a loss of 5hmC 
and impaired Tet1 binding, suggesting a role for Mbd3 in the 
maintenance of hydroxymethylated states. By contrast, Tet1 
is needed to recruit Mbd3, suggesting a positive feedback 
loop of the two interactors. Interestingly, Brg1, a member 
of the activating Swi/Snf chromatin remodeling complex, 
which antagonizes NuRD, also binds to sites occupied by 
Mbd3. The presence of two antagonistic complexes at a 
common set of targets might serve to keep an intact bal-
ance between repressive and active transcriptional domains 
creating a platform for transcriptional plasticity in pluripo-
tent cells  (52) . However, it still remains unclear if 5hmC 
interacts similarly with chromatin remodeling complexes in 
other cell types. 
 Tet3 function in oocytes and preimplantation 
embryos 
 Upon fertilization of the oocyte, the paternal genome rapidly 
loses 5mC and gains DNA hydroxymethylation. This is prob-
ably due to the activity of maternally provided Tet3, which is 
abundant in the oocyte, although the maternal genome itself 
shows little 5hmC (Figure 1)  (53, 54) . Hydroxymethylation 
established on the paternal genome remains globally sta-
ble through the fi rst cell divisions and shows a loss, which 
appears exclusively replication-dependent, as revealed by 
immunofl uorescence stainings  (26) . However, this obser-
vation does not exclude the possibility that single genomic 
regions or genes convert 5hmC to unmethylated cytosine. 
Indeed, conditional  Tet3 knockout (ko) in oocytes (driven 
by the  Zona pellucida 3 ( Zp3 ) promoter) leads to delayed 
activation of a paternally provided allele of the pluripotency 
marker  Oct4 , which is methylated in sperm and appears to 
be demethylated to allow for gene expression in the embryo 
 (54) . Nevertheless, it remains unclear if the global persis-
tence of 5hmC at the paternal genome in preimplantation 
embryos serves a crucial role in early embryonic develop-
ment. Oocyte-specifi c deletion of  Tet3 leads to developmental 
arrest of around half of embryos at mid-embryogenesis, but 
the other half are born alive and show normal fertility  (54) . 
As a mixed genetic background was used in these experi-
ments, cellular responses to the lack of Tet3 might depend 
on the individual genetic context leading to differential pen-
etrance of the mutant phenotype. Alternatively,  Zp3 -driven 
conditional  Tet3 deletion might, in some oocytes, lead to the 
presence of residual levels of the enzyme, because deletion 
may occur at slightly different time points in oogenesis. As 
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a consequence, low levels of Tet3 might just be enough to 
safeguard embryonic development. This possibility could be 
addressed by the use of an earlier promoter for conditional 
 Tet3 deletion. To date, detailed characterization of mecha-
nisms involving Tet3 in epigenetic gene regulation remains 
elusive, but its genome-wide profi ling in preimplantation 
embryos provides a technical challenge due to the small 
amount of cells (and DNA) available. Moreover, it is unclear 
if 5hmC that persists in early embryos is needed for transcrip-
tional regulation by recruitment of chromatin remodelers as 
has been described for ESCs  (52) . Interestingly, preimplanta-
tion development of parthenotes (generated by activation of 
an unfertilized oocyte and exclusively bearing the maternal 
genome) lacking high levels of 5hmC is unimpaired, sug-
gesting that hydroxymethylation of DNA is dispensable, at 
least in this specifi c scenario  (26) . 
 The role of Tet proteins in embryonic 
development 
 During the fi rst cellular divisions of the fertilized oocyte 
Tet3 is the major Tet family protein that is active, with Tet1 
and Tet2 becoming abundant only in the blastocyst (Figure 
1)  (20, 33, 34) . So far, ESC-based functional studies of Tet1 
have suggested an essential role in maintenance of the pluri-
potent state and in transcriptional up- and downregulation of 
distinct target gene sets, at least partly by generating 5hmC. 
However,  in vivo analysis of Tet1 function using a  Tet1 ko 
approach by homologous recombination revealed that mice 
lacking Tet1 are viable and fertile, although smaller at birth 
 (34) . Moreover,  Tet1 ko ESCs are self-renewing and pluri-
potent contradicting previous fi ndings using  Tet1 kd ESCs 
that lose pluripotency features and show skewing of their 
differentiation potential  (20, 29, 33) . Gene expression pro-
fi ling of  Tet1 ko ESCs revealed a deregulation of around 
200 genes, of which 60 % were downregulated and 40 % 
upregulated at least twofold. Compared to previous studies 
of Tet1 depletion using shRNA-mediated kd approaches, 
this only represents around one-sixth of genes previously 
found to be deregulated  (29 – 31) . When comparing several 
individual Tet1 kd studies, Tet1-deregulated genes show 
a rather poor overlap of around 10 % , although Tet1 bind-
ing sites were around 90 % identical  (35) . Nevertheless, 
all studies show relatively similar patterns of upregulated 
and downregulated genes, confi rming the dual function 
of Tet1 in transcriptional regulation. The discrepancies 
between  Tet1 ko and kd studies might be due to technical 
limitations of kd approaches such as off-target effects of 
retroviral-based constructs and incomplete depletion of 
transcripts and protein. By contrast, it is conceivable that 
variable expression levels of Tet enzymes (e.g., by different 
protein depletion effi ciencies) might generate different cel-
lular outcomes indicating biological variability in response 
to absolute Tet protein levels. Moreover, complete loss of 
Tet1 by a ko approach might cause Tet2 upregulation in 
ESCs, whereas incomplete removal of Tet1 by kd might not 
do so (or only to a lesser extent). 
 DNA demethylation via Tet in primordial germ 
cells ? 
 Despite global DNA demethylation in the zygote and main-
tenance of a hypomethylated state during the fi rst embry-
onic cleavages, imprinted loci are unaffected and remain 
differentially methylated. Shortly after implantation of 
the mouse embryo, some posterior proximal cells of the 
epiblast (the cells that give rise to the embryo proper in 
the implanted embryo) are specifi ed to develop PGCs at 
embryonic day (E) 6.25  (55, 56) . Nascent PGCs migrate to 
the genital ridges and populate the gonads between around 
E10.5 and E12.5, where they will differentiate into mature 
germ cells. As PGCs are derived from embryonic cells 
that have already acquired some somatic differentiation, 
they need to undergo epigenetic reprogramming towards a 
cellular state of higher plasticity  (57) . Moreover, for the 
proper setting of sex-specifi c genomic imprints in germ 
cells, the parentally inherited differentially methylated 
regions (DMRs) of somatic cell origin need to be erased. 
Between E8 and E11.5, PGCs are extensively demethylated 
and consistently they also display increased expression 
of  Tet1 and  Tet2 around E11 (Figure 1)  (58) . However, to 
date, it is unclear to what extent Tet enzymes contribute to 
imprint erasure. The observed loss of 5mC might be due 
to conversion to 5hmC or its processing to unmodifi ed 
cytosine by oxidation and/or BER  (58) . Although genetic 
approaches have shown that two players in BER, AID and 
TDG are at least in part required for proper demethylation 
in PGCs, their absence does not lead to a signifi cant loss 
of PGCs  (45, 59, 60) . During the biggest wave of global 
decrease of 5mC at around E11.5, no evidence has been 
found so far for the presence of AID or TDG  (60, 61) . Thus, 
other BER enzymes might be involved in the processing of 
5hmC in PGCs, either via metabolism to 5hmU or via Tet-
mediated oxidation products 5fC and 5caC. Alternatively, 
multiple parallel pathways of replication-dependent passive 
de methylation together with Tet-mediated active demethyla-
tion have been proposed as a high-fi delity mechanism for 
epigenetic reprogramming in developing germ cells  (58) . 
However, this model awaits confi rmation being challenged 
by the limited technical accessibility of PGCs. 
 Expert opinion 
 The fl urry of recent studies about Tet proteins and their prod-
ucts 5hmC, 5fC and 5caC have clearly demonstrated their 
importance in developmental processes. However, to date, 
most of the mechanistic information has been generated in 
ESCs, which are a rather limited model system in light of 
the cellular complexity of an entire organism. Especially 
with respect to the differential expression of the three Tet 
protein family members throughout the body, comprehen-
sive functional  in vivo data are still missing. Moreover, it 
is unclear if all three Tet enzymes could play redundant 
roles, as they might have distinct binding sites and inter-
act with different complexes, such as chromatin remodelers 
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or transcription factors in different cell types. Moreover, 
dependent on the interaction partners available, Tet proteins 
might trigger varying cellular responses as a result of their 
potential to regulate transcription and/or to generate DNA 
demethylation intermediates. The role of each player in this 
enzyme family needs to be further elucidated in different 
cell types, for example, by genome-wide analysis of their 
binding sites and biochemical studies of Tet protein interac-
tors. In addition, the relationship between Tet proteins and 
hydroxymethylation in epigenetic regulation is still unclear. 
Recent studies suggest that 5hmC is more than just a DNA 
demethylation intermediate and that it could function as an 
epigenetic mark on its own recruiting chromatin remodel-
ing complexes, as well as possibly transcription factors, his-
tone variants or histone modifying enzymes. With respect 
to DNA demethylation via 5hmC, different downstream 
pathways seem to exist, perhaps even in parallel to ensure 
accuracy of the process. 
 Outlook 
 Over the past few years, knowledge of Tet proteins and 5hmC 
has grown exponentially owing to the development of new 
techniques. The constant improvement of methods for even 
quantitative analysis of hydroxymethylation in the genome 
has allowed detailed analysis that will certainly be even more 
refi ned in the future. Genetic approaches aiming at condi-
tional deletion of more than one Tet enzyme at a time will 
provide insight into their (possible redundant) function in tis-
sues and organs. The necessity of the catalytic activity of Tet 
for their biological function might be addressed by express-
ing catalytically dead enzymes resulting in a loss of 5hmC in 
various cellular contexts. In the future, the establishment of a 
comprehensive network of Tet proteins and their interaction 
partners, as well as its role in hydroxymethylation and DNA 
demethylation in the context of development and disease is 
to be awaited. 
 Highlights 
 Tet proteins convert 5mC to 5hmC, 5fC and 5caC thereby • 
contributing to active DNA demethylation in mammalian 
genomes. 
 Tet proteins are transcriptional regulators, possibly partly • 
independent of their catalytic activity. 
 The redundant function of the three Tet protein family • 
members is currently unclear. 
 5hmC might function as an intermediate towards DNA • 
demethylation and as a regulatory mark. 
 Tissue specifi city of Tet- and 5hmC-mediated processes • 
needs to be addressed. 
 The establishment of a comprehensive epigenetic network • 
involving Tet proteins, their metabolites, chromatin regula-
tors and transcription factors in different cell types is to be 
awaited. 
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